ArticleNPJ digital medicine2026
Development of a multimodal large language model for early warning and diagnosis of chronic ocular GVHD.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Chronic ocular graft-versus-host disease (coGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) may lead to irreversible ocular surface damage and even vision loss. Current management of coGVHD faces challenges, with frequent missed or misdiagnosed cases. This study aimed to leverage a multimodal large language model (MLLM) to develop an early warning and diagnostic system for coGVHD. A total of 666 post-allo-HSCT patients (early warning model) and 805 post-allo-HSCT patients (1574 eyes, diagnostic model) were enrolled for construction, internal validation, and external validation of the corresponding models. We proposed the GVHD-MLLM, a multitask multimodal network that fused latent representations from four modal sequences to provide high-precision, real-time predictions for two tasks. The GVHD-MLLM achieved high performance in internal testing, with AUROCs of 93.44% (95% CI: 91.85-95.03%) for early warning, 98.98% (95% CI: 98.59-99.36%) for diagnosis, and 98.24% (95% CI: 98.05-98.43%) for disease severity grading. In external validation, the early warning AUROC was 83.45%, while diagnostic AUROCs across three external sites were all above 96.0%. The disease severity of patients seeking medical treatment after using the early warning model was significantly lower. Junior ophthalmologists also improved diagnostic accuracy using the model as an auxiliary tool. The GVHD-MLLM can process rich multi-modal information collected in clinical practice, and is expected to become an effective tool for managing coGVHD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.